AEDNX | CMRGX | AEDNX / CMRGX | |
Total Expense Ratio | 1.48 | 1.91 | 77% |
Annual Report Gross Expense Ratio | 1.50 | 12.31 | 12% |
Fund Existence | 15 years | 2 years | - |
Gain YTD | 3.112 | 1.623 | 192% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 1000000 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 58.4M | 2.05M | 2,849% |
Annual Yield % from dividends | 0.19 | 1.40 | 14% |
Returns for 1 year | 6.18 | 4.58 | 135% |
Returns for 3 years | 13.00 | N/A | - |
Returns for 5 years | 22.32 | N/A | - |
Returns for 10 years | 33.84 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYOIX | 64.30 | 1.10 | +1.74% |
Rydex Biotechnology Inv | |||
TRHZX | 158.13 | 1.63 | +1.04% |
T. Rowe Price Equity Index 500 Z | |||
FSHCX | 99.87 | 1.01 | +1.02% |
Fidelity Select Health Care Svcs Port | |||
BINIX | 31.07 | 0.31 | +1.01% |
Baron International Growth Institutional | |||
FFEIX | 14.21 | 0.14 | +1.00% |
Nuveen Dividend Value A |